![Foto de S.](/img/nophoto.png)
S.
Rayego Mateos
Publications dans lesquelles il/elle collabore avec S. Rayego Mateos (10)
2023
-
B- and T-lymphocyte attenuator could be a new player in accelerated atherosclerosis associated with chronic kidney disease
Clinical science (London, England : 1979), Vol. 137, Núm. 17, pp. 1409-1429
2022
-
The Increase in FGF23 Induced by Calcium Is Partially Dependent on Vitamin D Signaling
Nutrients, Vol. 14, Núm. 13
2021
-
Interleukin-17A: Potential mediator and therapeutic target in hypertension
Nefrologia
-
Interleuquina-17A: posible mediador y diana terapéutica en la hipertensión
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 41, Núm. 3, pp. 244-257
2020
-
IL‐17A as a potential therapeutic target for patients on peritoneal dialysis
Biomolecules, Vol. 10, Núm. 10, pp. 1-36
-
New therapeutic targets in chronic kidney disease progression and renal fibrosis
Expert Opinion on Therapeutic Targets, Vol. 24, Núm. 7, pp. 655-670
-
TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease
Journal of the American Society of Nephrology, Vol. 31, Núm. 9, pp. 2026-2042
2018
-
Epigenetic modification mechanisms involved in inflammation and fibrosis in renal pathology
Mediators of Inflammation, Vol. 2018
-
Role of epidermal growth factor receptor (EGFR) and its ligands in kidney inflammation and damage
Mediators of Inflammation, Vol. 2018
2015
-
Paricalcitol inhibits aldosterone-induced proinflammatory factors by modulating epidermal growth factor receptor pathway in cultured tubular epithelial cells
BioMed Research International, Vol. 2015